Loading…
Hikal (HIKAL)₹225.40+2.18%Pharmaceuticals
At the end of the Jun 2026 quarter, Hikal's shareholders were: promoters 68.82%, FIIs 0.97%, DIIs 7.28%, public 22.93%. Promoter holding is unchanged on the quarter. FII holding is down 4.34 percentage points from 5.31% a year earlier. 0.00% of promoter shares were pledged. It had 73,529 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 68.82% | 68.82% | 68.82% | 68.82% | 68.82% | 68.82% | 68.82% | 68.82% | 68.82% | 68.82% | 68.82% | 68.82% |
| FIIs | 4.77% | 6.09% | 6.50% | 6.61% | 6.73% | 6.01% | 5.66% | 5.31% | 4.20% | 2.29% | 1.43% | 0.97% |
| DIIs | 3.13% | 3.18% | 3.56% | 3.20% | 3.61% | 3.51% | 3.83% | 4.06% | 5.19% | 7.10% | 7.25% | 7.28% |
| Public | 23.28% | 21.91% | 21.12% | 21.37% | 20.84% | 21.66% | 21.69% | 21.81% | 21.79% | 21.79% | 22.50% | 22.93% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 76,128 | 74,659 | 71,842 | 70,980 | 71,914 | 71,803 | 68,909 | 71,393 | 73,406 | 74,119 | 74,272 | 73,529 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Kalyani Investment Company Limited | Promoter | 31.34% | 0.00 |
| Castilia Life Sciences Llp | Promoter | 24.53% | 0.00 |
| Sugandha J Hiremath | Promoter | 7.82% | 0.00 |
| Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund | DII | 3.27% | 0.00 |
| Tata Mutual Fund - Tata Small Cap Fund | DII | 2.69% | 0.00 |
| Bf Investment Limited | Promoter | 2.64% | 0.00 |
| Jai V Hiremath | Promoter | 1.10% | 0.00 |
| Pallavi Anish Swadi | Promoter | 0.46% | 0.00 |
| Sameer Jai Hiremath | Promoter | 0.32% | 0.00 |
| Sameer Trust | Promoter | 0.15% | 0.00 |
| Ashok Vishwanath Hiremath | Promoter | 0.08% | 0.00 |
| Anika Trust | Promoter | 0.06% | 0.00 |
| Anish Trust | Promoter | 0.06% | 0.00 |
| Nihal Trust | Promoter | 0.06% | 0.00 |
| Pooja Trust | Promoter | 0.06% | 0.00 |
| Rhea Trust | Promoter | 0.06% | 0.00 |
| Sumer Trust | Promoter | 0.06% | 0.00 |
| Anish Dilip Swadi | Promoter | 0.01% | 0.00 |
| Pooja Hiremath | Promoter | 0.01% | 0.00 |
Promoters held 68.82% of Hikal at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.97% (down 0.46 percentage points from 1.43% a quarter earlier) and domestic institutions (DIIs) held 7.28% (up 0.03 percentage points from 7.25% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Hikal had 73,529 shareholders at the end of the Jun 2026 quarter, against 71,393 a year earlier.
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund (DII) held 3.27% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.